2024 Cancer Research Grant Recipients
Maria Soledad Sosa, PhD
2024Associate Professor
Albert Einstein College of Medicine
Targeting dormant disseminated breast cancer cells to prevent metastasis formation
Gloria Echeverria, PhD
2024Assistant Professor
Baylor College of Medicine
Disrupting mitochondrial translation in chemoresistant triple negative breast cancer to overcome metabolic vulnerabilities
Sichun Yang, PhD
2024Associate Professor
CWRU Case Comprehensive Cancer Center
Targeting intrinsic ERalpha disorder to overcome antiestrogen resistance
Jennifer Hope, PhD
2024Assistant Professor
Drexel University
Targeting PSGL-1 to promote immune checkpoint blockade responsiveness in treatment-resistant triple negative breast cancer
Adrienne Boire, MD, PhD
2024Geoffrey Beene Junior Faculty Chair, Associate Attending Neurologist, Associate Member Human Oncology and Pathogenesis Program
Memorial Sloan Kettering Cancer Center
Breast Cancer Communication Across Brain Barriers
Erin Howe, PhD
2024Assistant Professor of Biochemistry and Molecular Biology, Center for Proteomics and Molecular Therapeutics
Rosalind Franklin University of Medicine & Science
Rab11 family interacting proteins control immune recognition of breast cancer brain metastases
Scott Abrams, PhD
2024Chair, Department of Immunology; Jacobs Family Endowed Chair of Immunology; Professor of Oncology
Roswell Park Comprehensive Cancer Center
Targeting the Immune Suppressive Tumor Microenvironment in Triple-Negative Breast Cancer to Improve Chemo-Immunotherapy Outcomes
Swarnali Acharyya, PhD
2024Associate Professor
The Trustees of Columbia University in the City of New York
Targeting PGF-FLT1 tumor microenvironment interactions to overcome PARP inhibitor resistance in breast cancer
Ernst Lengyel, PhD
2024Professor, Gynecologic Oncology
The University of Chicago
Methylation-based biomarkers for the detection and stratification of ovarian cancer in high-risk women
Pengda Liu, PhD
2024Associate Professor
The University of North Carolina at Chapel Hill
Statins suppress breast cancer metastasis by controlling canonical and non-canonical 2’3’-cGAMP signaling
Sarwish Rafiq, PhD
2024Assistant Professor
Emory University
Engaging the endogenous immune system using immune checkpoint inhibitors and CAR T cells
Lingtao Jin, PhD
2024Associate Professor, Department of Molecular Medicine
The University of Texas Health Science Center at San Antonio
Targeting novel protein kinase to improve taxane-based chemotherapy in ovarian cancer
2023 Cancer Research Grant Recipients
Dong-Joo (Ellen) Cheon
2023Associate Professor
Albany Medical College
Lipid-loaded macrophages as novel therapeutic targets in ovarian cancer
Valentina Hoyos Velez
2023Assistant Professor
Baylor College of Medicine
An immunopeptidomics-guided approach to refine target selection of breast cancer antigens for T cell receptor engineered T cell (TCR T) therapy
Nicole James
2023Assistant Professor
Brown University
Predictive Markers of Immunotherapy Response in Triple Negative Breast Cancer
John Maciejowski
2023Assistant Member
Memorial Sloan Kettering Cancer Center
Targeting the TREX1 Checkpoint to Improve Anti-Tumor Immunity
Lucia Borriello
2023Assistant Professor
Temple University – Of The Commonwealth System of Higher Education
Understanding the role of macrophages in tumor dormancy
Ghassan Mouneimne
2023Associate Professor
University of Arizona
Targeting matrix stiffness to block invasion progression of ER+ breast cancer
Justin Milner
2023Assistant Professor
The University of North Carolina at Chapel Hill
Tailoring CAR-T Cell Activity for Triple Negative Breast Cancer
Vishal Chandra
2023Assistant Professor
University of Oklahoma Health Sciences Center
Obesity Management Augmenting Endometrial Cancer prevention
Bodour Salhia
2023Associate Professor
University of Southern California
The development of OvaPrint, a cell-free DNA methylation test for the early detection of high-grade serious ovarian cancer
Marina Sharifi
2023Assistant Professor
The University of Wisconsin – Madison School of Medicine and Public Health
Identifying molecular drivers of PI3K inhibitor resistance in metastatic breast cancer via liquid biopsy
Isaac Chan
2023Assistant Professor
UT Southwestern Medical Center
Using natural killer cells to treat metastatic breast cancer
Matthew Greenblatt
2023Associate Professor
Weill Medical College of Cornell University
New Approaches to Target Vertebral Metastases in Breast Cancer
2022 Cancer Research Grant Recipients
Dr. Andrey Ivanov
2022EMORY UNIVERSITY
ASSISTANT PROFESSOR, DEPARTMENT OF PHARMACOLOGY & CHEMICAL BIOLOGY
Targeting MKK3-MYC complex to reduce racial survival disparity in breast cancer
Dr. Marikki Laiho
2022PROFESSOR OF RADIATION ONCOLOGY & ONCOLOGY
JOHNS HOPKINS UNIVERSITY
Rewiring of splicing programs in endometrial and ovarian cancers by new therapeutic agents
Dr. Samuel Bakhoum
2022ASSISTANT MEMBER, HUMAN ONCOLOGY & PATHOGENESIS PROGRAM; ASST. ATTENDING, DEPT. OF RADIATION ONCOLOGY
MEMORIAL SLOAN KETTERING CANCER CENTER
Examining the link between chromosomal instability and epigenetic alterations in High-Grade Serous Ovarian Cancer
Dr. Krzysztof Geras
2022ASSISTANT PROFESSOR
NYU GROSSMAN SCHOOL OF MEDICINE
Artificial Intelligence for Multi-Modal Breast Cancer Diagnosis
Dr. Gail Matters
2022ASSOCIATE PROFESSOR OF BIOCHEMISTRY & MOLECULAR BIOLOGY
PENN STATE COLLEGE OF MEDICINE
Detecting bone metastatic breast cancer by nanoparticle enhanced MRI
Dr. Tiffany Seagroves
2022PROFESSOR OF PATHOLOGY
Tulane School of Medicine
Targeting Creatine Kinase Brain Isoform (CKB) to Improve Survival from Breast Cancer Brain Metastasis
Dr. Diego Castrillon
2022PROFESSOR, DEPARTMENT OF PATHOLOGY
UT SOUTHWESTERN MEDICAL CENTER
Understanding the Initiation of Endometrial Cancer
Dr. Priyanka Verma
2022ASSISTANT PROFESSOR OF MEDICINE
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST. LOUIS
Inhibition of ALC1 ATPase activity as a new synthetic lethal strategy for BRCA-mutant cancers